The biology of equine mesenchymal stem cells: Phenotypic characterization, cell surface markers and multilineage differentiation

Frontiers in Bioscience

Volumn 17, Issue 3, 2012, Pages 892-908

  Penny, Jasmine ^a   Harris, Pat ^b   Shakesheff, Kevin ^c   Mobasheri, Ali ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b WALTHAM CENTRE FOR PET NUTRITION   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cell surface marker; Differentiation; Equine; Mesenchymal stem cell; Phenotypic characterization; Review

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; EQUIDAE; ORYCTOLAGUS CUNICULUS; RODENTIA;

EID: 84860342253     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3963     Document Type: Article

References (117)

1. EH Javazon, KJ Beggs and AW Flake: Mesenchymal stem cells: paradoxes of passaging. Exp Hematol, 32(5), 414-25 (2004). (Pubitemid 38624325)
2. SE Taylor, RK Smith and PD Clegg: Mesenchymal stem cell therapy in equine musculoskeletal disease: scientific fact or clinical fiction? Equine Vet J, 39(2), 172-80 (2007). (Pubitemid 351716181)
3. RK Smith and PM Webbon: Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn? Br J Sports Med, 39(9), 582-4 (2005). (Pubitemid 41265299)
4. TG Koch, LC Berg and DH Betts: Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine. Can Vet J, 50(2), 155-65 (2009).
5. M Dominici, K Le Blanc, I Mueller, I Slaper- Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315-7 (2006). (Pubitemid 44269669)
6. RO Oreffo, C Cooper, C Mason and M Clements: Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential. Stem Cell Rev, 1(2), 169-78 (2005). (Pubitemid 43074202)
7. S Sethe, A Scutt and A Stolzing: Aging of mesenchymal stem cells. Ageing Res Rev, 5(1), 91-116 (2006). (Pubitemid 43139669)
8. D Mrugala, C Bony, N Neves, L Caillot, S Fabre, D Moukoko, C Jorgensen and D Noel: Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model. Ann Rheum Dis, 67(3), 288-95 (2008). (Pubitemid 351281260)
9. AC Zannettino, S Paton, A Arthur, F Khor, S Itescu, JM Gimble and S Gronthos: Multipotential human adiposederived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol, 214(2), 413-21 (2008). (Pubitemid 350308998)
10. VL Battula, S Treml, PM Bareiss, F Gieseke, H Roelofs, P de Zwart, I Muller, B Schewe, T Skutella, WE Fibbe, L Kanz and HJ Buhring: Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen- 1. Haematologica, 94(2), 173-84 (2009).
11. RC McCarty, S Gronthos, AC Zannettino, BK Foster and CJ Xian: Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells. J Cell Physiol, 219(2), 324-33 (2009).
12. M Brohlin, D Mahay, LN Novikov, G Terenghi, M Wiberg, SG Shawcross and LN Novikova: Characterisation of human mesenchymal stem cells following differentiation into Schwann cell-like cells. Neurosci Res, 64(1), 41-9 (2009).
13. N Vieira, V Brandalise, E Zucconi, M Secco, B Strauss and M Zatz: Isolation, characterization and differentiation potential of canine adipose-derived stem cells. Cell Transplant (2009).
14. MS Seo, YH Jeong, JR Park, SB Park, KH Rho, HS Kim, KR Yu, SH Lee, JW Jung, YS Lee and KS Kang: Isolation and characterization of canine umbilical cord blood-derived mesenchymal stem cells. J Vet Sci, 10(3), 181-7 (2009).
15. SH Mirmalek-Sani, RS Tare, SM Morgan, HI Roach, DI Wilson, NA Hanley and RO Oreffo: Characterization and multipotentiality of human fetal femur-derived cells: implications for skeletal tissue regeneration. Stem Cells, 24(4), 1042-53 (2006). (Pubitemid 44464737)
16. BD MacArthur, RS Tare, K Murawski and RO Oreffo: Identification of candidate regulators of multipotency in human skeletal progenitor cells. Biochem Biophys Res Commun, 377(1), 68-72 (2008).
17. PJ Simmons and B Torok-Storb: Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood, 78(1), 55- 62 (1991).
18. S Gronthos, SE Graves, S Ohta and PJ Simmons: The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood, 84(12), 4164-73 (1994). (Pubitemid 24371919)
19. BG Sengers, JI Dawson and RO Oreffo: Characterisation of human bone marrow stromal cell heterogeneity for skeletal regeneration strategies using a two-stage colony assay and computational modelling. Bone, 46(2), 496-503 (2010).
20. S Otsuki, SP Grogan, S Miyaki, M Kinoshita, H Asahara and MK Lotz: Tissue neogenesis and STRO-1 expression in immature and mature articular cartilage. J Orthop Res, 28(1), 96-102 (2010).
21. RL Mauck, X Yuan and RS Tuan: Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture. Osteoarthritis Cartilage, 14(2), 179-89 (2006). (Pubitemid 43079315)
22. MB Eslaminejad and L Taghiyar: Study of the Structure of Canine Mesenchymal Stem Cell Osteogenic Culture. Anat Histol Embryol (2010).
23. SJ Arnhold, I Goletz, H Klein, G Stumpf, LA Beluche, C Rohde, K Addicks and LF Litzke: Isolation and characterization of bone marrow-derived equine mesenchymal stem cells. Am J Vet Res, 68(10), 1095- 105 (2007). (Pubitemid 47616621)
24. LR Goodrich and AJ Nixon: Medical treatment of osteoarthritis in the horse - a review. Vet J, 171(1), 51-69 (2006). (Pubitemid 43116335)
25. CW McIlwraith, DD Frisbie, CE Kawcak, CJ Fuller, M Hurtig and A Cruz: The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the horse. Osteoarthritis Cartilage, 18 Suppl 3, S93-105 (2010).
26. FH Chen and RS Tuan: Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther, 10(5), 223 (2008).
27. DT Felson: Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther, 11(1), 203 (2009).
28. A Mobasheri, C Csaki, AL Clutterbuck, M Rahmanzadeh and M Shakibaei: Mesenchymal stem cells in connective tissue engineering and regenerative medicine: applications in cartilage repair and osteoarthritis therapy. Histol Histopathol, 24(3), 347-66 (2009).
29. ND Miljkovic, GM Cooper and KG Marra: Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthritis Cartilage, 16(10), 1121-30 (2008).
30. SM Richardson, JA Hoyland, R Mobasheri, C Csaki, M Shakibaei and A Mobasheri: Mesenchymal stem cells in regenerative medicine: opportunities and challenges for articular cartilage and intervertebral disc tissue engineering. J Cell Physiol, 222(1), 23-32 (2010).
31. C Buhrmann, A Mobasheri, U Matis and M Shakibaei: Curcumin mediated suppression of nuclear factor-kappaB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment. Arthritis Res Ther, 12(4), R127 (2010).
32. SB Abramson and M Attur: Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther, 11(3), 227 (2009).
33. SM Richardson, A Mobasheri, AJ Freemont and JA Hoyland: Intervertebral disc biology, degeneration and novel tissue engineering and regenerative medicine therapies. Histol Histopathol, 22(9), 1033-41 (2007). (Pubitemid 47034169)
34. C Csaki, A Mobasheri and M Shakibaei: Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1betainduced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther, 11(6), R165 (2009).
35. Y Liu, R Mu, S Wang, L Long, X Liu, R Li, J Sun, J Guo, X Zhang, P Yu, C Li, Z Huang, D Wang, H Li, Z Gu, B Liu and Z Li: Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther, 12(6), R210 (2010).
36. CT Thorpe, PD Clegg and HL Birch: A review of tendon injury: why is the equine superficial digital flexor tendon most at risk? Equine Vet J, 42(2), 174-80 (2010).
37. S Violini, P Ramelli, LF Pisani, C Gorni and P Mariani: Horse bone marrow mesenchymal stem cells express embryo stem cell markers and show the ability for tenogenic differentiation by in vitro exposure to BMP-12. BMC Cell Biol, 10, 29 (2009).
38. LE Richardson, J Dudhia, PD Clegg and R Smith: Stem cells in veterinary medicine-attempts at regenerating equine tendon after injury. Trends Biotechnol, 25(9), 409- 16 (2007). (Pubitemid 350147117)
39. M Krampera, G Pizzolo, G Aprili and M Franchini: Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone, 39(4), 678-83 (2006). (Pubitemid 44311724)
40. MN Helder, M Knippenberg, J Klein-Nulend and PI Wuisman: Stem cells from adipose tissue allow challenging new concepts for regenerative medicine. Tissue Eng, 13(8), 1799-808 (2007). (Pubitemid 47293982)
41. A Papathanasopoulos and PV Giannoudis: Biological considerations of mesenchymal stem cells and endothelial progenitor cells. Injury, 39 Suppl 2, S21-32 (2008).
42. KH Kraus and C Kirker-Head: Mesenchymal stem cells and bone regeneration. Vet Surg, 35(3), 232-42 (2006).
43. A Crovace, L Lacitignola, G Rossi and E Francioso: Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon. Vet Med Int, 2010, 250978 (2010).
44. RK Smith, M Korda, GW Blunn and AE Goodship: Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J, 35(1), 99- 102 (2003). (Pubitemid 39663047)
45. DJ Guest, MR Smith and WR Allen: Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon. Equine Vet J, 42(7), 636-42 (2010).
46. MM Wilke, DV Nydam and AJ Nixon: Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res, 25(7), 913-25 (2007). (Pubitemid 47046438)
47. J Koerner, D Nesic, JD Romero, W Brehm, P Mainil- Varlet and SP Grogan: Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells. Stem Cells, 24(6), 1613-9 (2006). (Pubitemid 44464679)
48. S Giovannini, W Brehm, P Mainil-Varlet and D Nesic: Multilineage differentiation potential of equine blood-derived fibroblast-like cells. Differentiation, 76(2), 118-29 (2008). (Pubitemid 351197178)
49. C Bourzac, LC Smith, P Vincent, G Beauchamp, JP Lavoie and S Laverty: Isolation of equine bone marrowderived mesenchymal stem cells: a comparison between three protocols. Equine Vet J, 42(6), 519-27 (2010).
50. S Kern, H Eichler, J Stoeve, H Kluter and K Bieback: Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24(5), 1294-301 (2006). (Pubitemid 44464698)
51. TG Koch, T Heerkens, PD Thomsen and DH Betts: Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol, 7, 26 (2007).
52. A de Mattos Carvalho, AL Alves, MA Golim, A Moroz, CA Hussni, PG de Oliveira and E Deffune: Isolation and immunophenotypic characterization of mesenchymal stem cells derived from equine species adipose tissue. Vet Immunol Immunopathol, 132(2-4), 303- 6 (2009).
53. L Pascucci, F Mercati, C Marini, P Ceccarelli, C Dall'Aglio, V Pedini and AM Gargiulo: Ultrastructural morphology of equine adipose-derived mesenchymal stem cells. Histol Histopathol, 25(10), 1277-85 (2010).
54. JD Kisiday, PW Kopesky, CH Evans, AJ Grodzinsky, CW McIlwraith and DD Frisbie: Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. J Orthop Res, 26(3), 322-31 (2008).
55. SM Hoynowski, MM Fry, BM Gardner, MT Leming, JR Tucker, L Black, T Sand and KE Mitchell: Characterization and differentiation of equine umbilical cord-derived matrix cells. Biochem Biophys Res Commun, 362(2), 347-53 (2007). (Pubitemid 47334921)
56. AA Worster, BD Brower-Toland, LA Fortier, SJ Bent, J Williams and AJ Nixon: Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-beta1 in monolayer and insulinlike growth factor-I in a three-dimensional matrix. J Orthop Res, 19(4), 738-49 (2001). (Pubitemid 32700992)
57. LA Fortier, AJ Nixon, J Williams and CS Cable: Isolation and chondrocytic differentiation of equine bone marrow-derived mesenchymal stem cells. Am J Vet Res, 59(9), 1182-7 (1998). (Pubitemid 128472445)
58. MA Vidal, GE Kilroy, JR Johnson, MJ Lopez, RM Moore and JM Gimble: Cell growth characteristics and differentiation frequency of adherent equine bone marrowderived mesenchymal stromal cells: adipogenic and osteogenic capacity. Vet Surg, 35(7), 601-10 (2006). (Pubitemid 44526659)
59. V Lettry, K Hosoya, S Takagi and M Okumura: Coculture of equine mesenchymal stem cells and mature equine articular chondrocytes results in improved chondrogenic differentiation of the stem cells. Jpn J Vet Res, 58(1), 5-15 (2010).
60. JC Kiefer: Back to basics: Sox genes. Dev Dyn, 236(8), 2356-66 (2007).
61. M Wegner: All purpose Sox: The many roles of Sox proteins in gene expression. Int J Biochem Cell Biol, 42(3), 381-90 (2010).
62. C Csaki, U Matis, A Mobasheri and M Shakibaei: Coculture of canine mesenchymal stem cells with primary bone-derived osteoblasts promotes osteogenic differentiation. Histochem Cell Biol, 131(2), 251-66 (2009).
63. TA Rege and JS Hagood: Thy-1 as a regulator of cellcell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. Faseb J, 20(8), 1045-54 (2006). (Pubitemid 44943900)
64. C Csaki, U Matis, A Mobasheri, H Ye and M Shakibaei: Chondrogenesis, osteogenesis and adipogenesis of canine mesenchymal stem cells: a biochemical, morphological and ultrastructural study. Histochem Cell Biol, 128(6), 507-20 (2007). (Pubitemid 350112777)
65. AA Hegewald, J Ringe, J Bartel, I Kruger, M Notter, D Barnewitz, C Kaps and M Sittinger: Hyaluronic acid and autologous synovial fluid induce chondrogenic differentiation of equine mesenchymal stem cells: a preliminary study. Tissue Cell, 36(6), 431-8 (2004). (Pubitemid 39481203)
66. AA Stewart, CR Byron, H Pondenis and MC Stewart: Effect of fibroblast growth factor-2 on equine mesenchymal stem cell monolayer expansion and chondrogenesis. Am J Vet Res, 68(9), 941-5 (2007). (Pubitemid 47408323)
67. AA Stewart, CR Byron, HC Pondenis and MC Stewart: Effect of dexamethasone supplementation on chondrogenesis of equine mesenchymal stem cells. Am J Vet Res, 69(8), 1013-21 (2008).
68. SJ Murray, KS Santangelo and AL Bertone: Evaluation of early cellular influences of bone morphogenetic proteins 12 and 2 on equine superficial digital flexor tenocytes and bone marrow-derived mesenchymal stem cells in vitro. Am J Vet Res, 71(1), 103-14 (2010).
69. RS Carpenter, LR Goodrich, DD Frisbie, JD Kisiday, B Carbone, CW McIlwraith, CJ Centeno and C Hidaka: Osteoblastic differentiation of human and equine adult bone marrow-derived mesenchymal stem cells when BMP- 2 or BMP-7 homodimer genetic modification is compared to BMP-2/7 heterodimer genetic modification in the presence and absence of dexamethasone. J Orthop Res (2010).
70. DA Clark and R Coker: Transforming growth factorbeta (TGF-beta). Int J Biochem Cell Biol, 30(3), 293-8 (1998).
71. DM Kingsley: The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev, 8(2), 133-46 (1994).
72. MB Sporn and AB Roberts: TGF-beta: problems and prospects. Cell Regul, 1(12), 875-82 (1990).
73. B Bragdon, O Moseychuk, S Saldanha, D King, J Julian and A Nohe: Bone Morphogenetic Proteins: A critical review. Cell Signal (2010).
74. JK Dow and RW deVere White: Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions. Urology, 55(6), 800-6 (2000). (Pubitemid 30330774)
75. C Shukunami, A Takimoto, M Oro and Y Hiraki: Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes. Dev Biol, 298(1), 234-47 (2006). (Pubitemid 44414808)
76. D Docheva, EB Hunziker, R Fassler and O Brandau: Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol, 25(2), 699-705 (2005). (Pubitemid 40096590)
77. H Tempfer, A Wagner, R Gehwolf, C Lehner, M Tauber, H Resch and HC Bauer: Perivascular cells of the supraspinatus tendon express both tendon- and stem cellrelated markers. Histochem Cell Biol, 131(6), 733-41 (2009).
78. H Kamishina, J Deng, T Oji, JA Cheeseman and RM Clemmons: Expression of neural markers on bone marrowderived canine mesenchymal stem cells. Am J Vet Res, 67(11), 1921-8 (2006). (Pubitemid 44782161)
79. T Martinello, I Bronzini, L Maccatrozzo, A Mollo, M Sampaolesi, F Mascarello, M Decaminada and M Patruno: Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation. Res Vet Sci (2010).
80. G Chamberlain, J Fox, B Ashton and J Middleton: Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells, 25(11), 2739-49 (2007). (Pubitemid 350127858)
81. N Holmes: CD45: all is not yet crystal clear. Immunology, 117(2), 145-55 (2006).
82. JS Nielsen and KM McNagny: Novel functions of the CD34 family. J Cell Sci, 121(Pt 22), 3683-92 (2008).
83. MA Vidal, SO Robinson, MJ Lopez, DB Paulsen, O Borkhsenious, JR Johnson, RM Moore and JM Gimble: Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow. Vet Surg, 37(8), 713-24 (2008).
84. S Colleoni, E Bottani, I Tessaro, G Mari, B Merlo, N Romagnoli, A Spadari, C Galli and G Lazzari: Isolation, growth and differentiation of equine mesenchymal stem cells: effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor. Vet Res Commun (2009).
85. L da Silva Meirelles, TT Sand, RJ Harman, DP Lennon and AI Caplan: MSC frequency correlates with blood vessel density in equine adipose tissue. Tissue Eng Part A, 15(2), 221-9 (2009).
86. M Del Bue, S Ricco, V Conti, E Merli, R Ramoni and S Grolli: Platelet lysate promotes in vitro proliferation of equine mesenchymal stem cells and tenocytes. Vet Res Commun, 31 Suppl 1, 289-92 (2007). (Pubitemid 47244326)
87. L da Silva Meirelles, PC Chagastelles and NB Nardi: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci, 119(Pt 11), 2204-13 (2006). (Pubitemid 43960310)
88. AI Caplan: All MSCs are pericytes? Cell Stem Cell, 3(3), 229-30 (2008).
89. U Lindner, J Kramer, J Rohwedel and P Schlenke: Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology? Transfus Med Hemother, 37(2), 75-83 (2010).
90. M Crisan, S Yap, L Casteilla, CW Chen, M Corselli, TS Park, G Andriolo, B Sun, B Zheng, L Zhang, C Norotte, PN Teng, J Traas, R Schugar, BM Deasy, S Badylak, HJ Buhring, JP Giacobino, L Lazzari, J Huard and B Peault: A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell, 3(3), 301-13 (2008).
91. R Cancedda, P Castagnola, FD Cancedda, B Dozin and R Quarto: Developmental control of chondrogenesis and osteogenesis. Int J Dev Biol, 44(6), 707-14 (2000).
92. MB Goldring, K Tsuchimochi and K Ijiri: The control of chondrogenesis. J Cell Biochem, 97(1), 33-44 (2006). (Pubitemid 43050970)
93. K Pelttari, E Steck and W Richter: The use of mesenchymal stem cells for chondrogenesis. Injury, 39 Suppl 1, S58-65 (2008).
94. I Onyekwelu, MB Goldring and C Hidaka: Chondrogenesis, joint formation, and articular cartilage regeneration. J Cell Biochem, 107(3), 383-92 (2009).
95. S Boeuf and W Richter: Chondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors. Stem Cell Res Ther, 1(4), 31 (2010).
96. G Bianchi, A Banfi, M Mastrogiacomo, R Notaro, L Luzzatto, R Cancedda and R Quarto: Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res, 287(1), 98-105 (2003). (Pubitemid 36683205)
97. LA Solchaga, K Penick, JD Porter, VM Goldberg, AI Caplan and JF Welter: FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrowderived mesenchymal stem cells. J Cell Physiol, 203(2), 398-409 (2005). (Pubitemid 40471774)
98. PA Sotiropoulou, SA Perez, M Salagianni, CN Baxevanis and M Papamichail: Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells, 24(2), 462-71 (2006). (Pubitemid 44464816)
99. TG Koch, PD Thomsen and DH Betts: Improved isolation protocol for equine cord blood-derived mesenchymal stromal cells. Cytotherapy, 11(4), 443-7 (2009).
100. SA Reed and SE Johnson: Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types. J Cell Physiol, 215(2), 329-36 (2008). (Pubitemid 351468944)
101. EM Schuh, MS Friedman, DD Carrade, J Li, D Heeke, SM Oyserman, LD Galuppo, DJ Lara, NJ Walker, GL Ferraro, SD Owens and DL Borjesson: Identification of variables that optimize isolation and culture of multipotent mesenchymal stem cells from equine umbilical-cord blood. Am J Vet Res, 70(12), 1526-35 (2009).
102. M Kanichai, D Ferguson, PJ Prendergast and VA Campbell: Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: a role for AKT and hypoxiainducible factor (HIF)-1alpha. J Cell Physiol, 216(3), 708-15 (2008).
103. JB Mitchell, K McIntosh, S Zvonic, S Garrett, ZE Floyd, A Kloster, Y Di Halvorsen, RW Storms, B Goh, G Kilroy, X Wu and JM Gimble: Immunophenotype of human adiposederived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells, 24(2), 376-85 (2006). (Pubitemid 44464807)
104. E Leonardi, V Devescovi, F Perut, G Ciapetti and A Giunti: Isolation, characterisation and osteogenic potential of human bone marrow stromal cells derived from the medullary cavity of the femur. Chir Organi Mov, 92(2), 97-103 (2008).
105. MC Kastrinaki, P Sidiropoulos, S Roche, J Ringe, S Lehmann, H Kritikos, VM Vlahava, B Delorme, GD Eliopoulos, C Jorgensen, P Charbord, T Haupl, DT Boumpas and HA Papadaki: Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann Rheum Dis, 67(6), 741-9 (2008). (Pubitemid 351829372)
106. WS Khan, AB Adesida and TE Hardingham: Hypoxic conditions increase hypoxia-inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthritis Res Ther, 9(3), R55 (2007).
107. WS Khan, SR Tew, AB Adesida and TE Hardingham: Human infrapatellar fat pad-derived stem cells express the pericyte marker 3G5 and show enhanced chondrogenesis after expansion in fibroblast growth factor-2. Arthritis Res Ther, 10(4), R74 (2008).
108. WS Khan, AB Adesida, SR Tew, JG Andrew and TE Hardingham: The epitope characterisation and the osteogenic differentiation potential of human fat pad-derived stem cells is maintained with ageing in later life. Injury, 40(2), 150-7 (2009).
109. NM Castrechini, P Murthi, NM Gude, JJ Erwich, S Gronthos, A Zannettino, SP Brennecke and B Kalionis: Mesenchymal stem cells in human placental chorionic villi reside in a vascular Niche. Placenta, 31(3), 203-12 (2010).
110. C Wickenhauser, B Schmitz, SE Baldus, F Henze, P Farahmand, S Frimpong, J Thiele and R Fischer: Selectins (CD62L, CD62P) and megakaryocytic glycoproteins (CD41a, CD42b) mediate megakaryocyte-fibroblast interactions in human bone marrow. Leuk Res, 24(12), 1013-21 (2000).
111. AV Delgado, SL Alexander, AT McManus and AE Pusateri: Antibodies against human cell receptors, CD36, CD41a, and CD62P crossreact with porcine platelets. Cytometry B Clin Cytom, 56(1), 62-7 (2003). (Pubitemid 38292617)
112. BM Stramer, MG Kwok, PJ Farthing-Nayak, JC Jung, ME Fini and RC Nayak: Monoclonal antibody (3G5)- defined ganglioside: cell surface marker of corneal keratocytes. Invest Ophthalmol Vis Sci, 45(3), 807-12 (2004). (Pubitemid 38868375)
113. SY Choo: The HLA system: genetics, immunology, clinical testing, and clinical implications. Yonsei Med J, 48(1), 11-23 (2007). (Pubitemid 46403628)
114. PJ Bjorkman and P Parham: Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem, 59, 253-88 (1990).
115. MJ Androlewicz: Peptide generation in the major histocompatibility complex class I antigen processing and presentation pathway. Curr Opin Hematol, 8(1), 12-6 (2001). (Pubitemid 32047656)
116. SN Brimble, ES Sherrer, EW Uhl, E Wang, S Kelly, AH Merrill, Jr., AJ Robins and TC Schulz: The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency. Stem Cells, 25(1), 54-62 (2007). (Pubitemid 46052974)
117. WM Schopperle and WC DeWolf: The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells, 25(3), 723-30 (2007). (Pubitemid 46354232)